MBCGX | RGEBX | MBCGX / RGEBX | |
Total Expense Ratio | 1.15 | 1.09 | 106% |
Annual Report Gross Expense Ratio | 1.15 | 1.09 | 106% |
Fund Existence | 24 years | 11 years | - |
Gain YTD | 14.286 | 17.063 | 84% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.17B | 337B | 1% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 20.11 | 12.00 | 168% |
Returns for 3 years | 29.17 | 70.28 | 42% |
Returns for 5 years | -16.27 | 44.30 | -37% |
Returns for 10 years | 37.41 | 106.30 | 35% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPCX | 12.99 | 0.19 | +1.48% |
Saratoga Health & Biotechnology C | |||
PFRSX | 28.40 | 0.26 | +0.92% |
Principal Real Estate Securities Fd R6 | |||
CLSYX | 22.12 | 0.11 | +0.50% |
Columbia International Div Inc Inst3 | |||
AGRYX | 145.83 | 0.67 | +0.46% |
AB Growth Advisor | |||
MSLLX | 20.81 | 0.03 | +0.14% |
Morgan Stanley Inst Passport ovrs eq L |